on EUROBIO-SCIENTIFIC (EPA:ALERS)
Eurobio Scientific: a look back at the successful takeover bid with an imminent reopening
On November 29, 2024, Eurobio Scientific and EB Development announced the success of the public tender offer (OPA) launched by EB Development. The AMF confirmed that 44.72% of the capital and voting rights of Eurobio Scientific had been contributed to this offer.
At the closing of the offer on November 27, 4,582,971 shares had been tendered. EB Development, in collaboration with NextStage AM, IK Partners, and Eurobio executives, thus holds 82.68% of the capital. The reopening of the offer is scheduled from December 4 to 17, 2024.
The takeover bid price is 25.30 euros per share, plus a supplement of 1.25 euros if 90% of the capital is reached. Excluding the supplement, the offer represents a premium of 39% on the last closing price before the announcement.
The board of directors recommends that shareholders tender their shares, stressing that the listing no longer promotes the company's development.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all EUROBIO-SCIENTIFIC news